Prostamax 20mg
Prostamax is a synthetic tetrapeptide composed of Lys-Glu-Asp-Pro (KEDP), with a molecular weight of approximately 487.5 g/mol. Supplied as a lyophilized powder for laboratory research and analytical use only. Not intended for human or veterinary use, including consumption, injection, topical application, or any diagnostic, therapeutic, or clinical purpose.
Certificate of Analysis (COA)
Click “Check the COA” in the product section above to access the available Certificate of Analysis for this product. Please refer to the report for batch information and analytical results.
For laboratory research use only. Not for human or veterinary use.
Prostamax Structure
PubChem - Sequence:KEDP
- Molecular Formula:C20H33N5O9
- Molecular Weight:487.5 g/mol
- PubChem CID:9848296
Prostamax Research
Prostamax is a synthetic tetrapeptide composed of Lys-Glu-Asp-Pro (KEDP), with a molecular weight of approximately 487.5 g/mol. Supplied as a lyophilized powder for laboratory research and analytical use only. Not intended for human or veterinary use, including consumption, injection, topical application, or any diagnostic, therapeutic, or clinical purpose.
Relevant Citations
References
[1] Khavinson V K, Lezhava T A, Malinin V V. Effects of short peptides on lymphocyte chromatin in senile subjects[J]. Bulletin of Experimental Biology and Medicine, 2004,137(1):78-81.
DOI:10.1023/B:BEBM.0000024393.40560.05.
[2] Kiladze M, Gorgoshidze M, Monaselidze J, et al. Microcalorimetric study of human blood lymphocytes culture at presence of copper, cadmium and prostamax[J]. Georgian Medical News, 2009,(168):104-107.
PMID:19359734.
[3] Meskhi T, Khachidze D, Barbakadze S, et al. [The influence of the peptide bioregulator prostamax on heterochromatin of human lymphocytes in situ][J]. Biofizika, 2004,49(6):1091-1093.
PMID:15612551.
[4] Zakutskiĭ A N, Chalisova N I, Ryzhak G A, et al. [The tissue-specific effect of synthetic peptides-biologic regulators in organotypic tissues culture in young and old rats][J]. Advances in Gerontology, 2006,19:93-96.
PMID:17152728.
[5] Borovskaya T G, Pakhomova A V, Vychuzhanina A V, et al. Experimental studying of the drug efficiency Prostamax in the therapy of chronic aseptic prostatitis and its complications[J]. Modern Research in Inflammation, 2013,2:54-58.
DOI:10.4236/mri.2013.23007.
[6] NCBI PubChem. Prostamax. PubChem CID 9848296.
ALL PRODUCTS, ARTICLES, TECHNICAL MATERIALS, PRODUCT DESCRIPTIONS, AND OTHER INFORMATION PROVIDED ON THIS WEBSITE ARE INTENDED SOLELY FOR LEGITIMATE LABORATORY RESEARCH, INFORMATIONAL, AND EDUCATIONAL PURPOSES.
Products offered by Cocer Peptides are intended exclusively for in vitro and laboratory research and are NOT intended for human or veterinary use, human consumption, clinical use, diagnostic use, therapeutic use, compounding, self-administration, injection, or any other form of administration to humans or animals. These products are not intended to diagnose, treat, cure, mitigate, or prevent any disease or medical condition, nor are they intended to affect the structure or function of the human or animal body. Unless expressly stated otherwise, products offered on this website have not been evaluated or approved by the U.S. Food and Drug Administration (FDA) for human or veterinary use. Any references to published studies, biochemical pathways, molecular mechanisms, or experimental findings are provided solely for scientific discussion and research purposes and do not constitute medical advice, therapeutic claims, dosing guidance, or instructions for use. Purchasers are solely responsible for ensuring that all products are acquired, handled, stored, used, and disposed of in accordance with applicable laws, regulations, institutional requirements, and laboratory safety standards.